Potential of Anti-CMV Immunoglobulin Cytotect CP(®) In Vitro and Ex Vivo in a First-Trimester Placenta Model

Background: Congenital CMV infection is the leading cause of neonatal neurological deficit. We herein studied in vitro and ex vivo the potential of the hyperimmune globulin Cytotect CP(®) (Biotest, Germany) for congenital infection prevention and treatment. Methods: In vitro neutralization assays we...

Descripción completa

Detalles Bibliográficos
Autores principales: Coste Mazeau, Perrine, Jacquet, Chloé, Muller, Clotilde, Courant, Mathis, El Hamel, Chahrazed, Chianea, Thierry, Hantz, Sébastien, Alain, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030298/
https://www.ncbi.nlm.nih.gov/pubmed/35456746
http://dx.doi.org/10.3390/microorganisms10040694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030298/
https://www.ncbi.nlm.nih.gov/pubmed/35456746
http://dx.doi.org/10.3390/microorganisms10040694

Ejemplares similares